Translating economic evaluations into financing strategies for implementing evidence-based practices.

Translating economic evaluations into financing strategies for implementing evidence-based practices.
Implementation Sci 16, 66 (2021). https://doi.org/10.1186/s13012-021-01137-9

• Implementation researchers are increasingly using economic evaluation to explore the benefits produced by implementing evidence-based practices (EBPs) in healthcare settings. However, the findings of typical economic evaluations (e.g., based on clinical trials) are rarely sufficient to inform decisions about how health service organizations and policymakers should finance investments in EBPs. This paper describes how economic evaluations can be translated into policy and practice through complementary research on financing strategies that support EBP implementation and sustainment.

Cost effectiveness analysis and cost utility analysis of digital health products

Three economics resources in the guide to evaluating digital health products

Guidance: Cost benefit analysis: health economic studies

PHE 9 November 2020

Guidance: Cost effectiveness analysis
PHE 13 October 2020

Guidance: Cost utility analysis
PHE 13 October 2020

At What cost? - the economic impact of stroke in Europe

At What Cost – the Economic Impact of Stroke in Europe
SAFE (Stroke Alliance for Europe) 2 October 2020

• The report covers:
• current cost of stroke along the whole stroke care pathway, including direct healthcare costs, the costs of informal care and productivity losses due to disability or death from stroke
• projected future stroke costs for the next 20 years
• analysis of three interventions in the latest stroke guidelines - the treatment of atrial fibrillation to prevent stroke, mechanical thrombectomy (the clot retrieval from the blood vessel in the brain) in the acute phase of stroke and community-based rehabilitation after stroke.

What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England?

What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation
BMJ Open 2020;10:e037486. doi: 10.1136/bmjopen-2020-037486

• An economic analysis using the School for Public Health Research CVD Prevention Model indicates that £68 billion could be saved, 4.9 million QALYs gained and 3.4 million cases of CVD prevented over 25 years if all individuals in England with the six CVD high risk conditions were diagnosed and subsequently managed at current levels.

The economic influence of the NHS at the local level

The economic influence of the NHS at the local level
Kings Fund 16 January 2020

• As the biggest employer in England and a significant economic force in local communities, the NHS has a unique opportunity to use its resources to influence the wellbeing of the population it serves and reduce the health inequalities that exist in England. 
• This long read looks at the NHS’s role within the wider economy from several perspectives – the level of influence the NHS holds through employment and spending; the relative level of earnings in the NHS compared to the wider local economy; and the provision of training, skills and opportunity.

PMH47 THE IMPACT OF A DIGITAL SLEEP-IMPROVEMENT PROGRAM ON HEALTH CARE COSTS

PMH47 THE IMPACT OF A DIGITAL SLEEP-IMPROVEMENT PROGRAM ON HEALTH CARE COSTS
Value in Health V22, SUPPLEMENT 3, S689, November 2019

• Access to non-pharmacological interventions for insomnia is limited, despite evidence for their effectiveness. This is due in part to a shortage of trained providers. Digital cognitive behavioural therapy for insomnia (dCBT-I), which requires less input per session, is therefore an attractive complement or substitute to face-to-face cognitive behavioural therapy. Sleepio is a self-help programme for sleep improvement, which has been shown to improve sleep quality. However, there is little evidence available regarding its impact on health care use. In this study, we sought to identify whether providing access to Sleepio results in a change in the trend of patients' primary care costs.

Outcome from Sleepio health economic evaluation 

See also 

• Conference paper: Health Economists' Study Group Jan 2020

Comprehensive Investment Appraisal Model and guidance for the NHS

Comprehensive Investment Appraisal (CIA) Model and guidance
DHSC 9 April 2019

• The CIA Model is for use by the NHS to support economic appraisals in business cases. It replaces the Generic Economic Model (GEM).
• The user guide shows how the CIA Model can be used to support economic appraisals in business cases. It provides guidance on the key economic principles, how these are used in economic appraisals and how the outcome of these appraisals is interpreted.

Methods for the Economic Evaluation of Changes to the Organisation and Delivery of Health Services: Principal Challenges and Recommendations

Methods for the Economic Evaluation of Changes to the Organisation and Delivery of Health Services: Principal Challenges and Recommendations
Health Econ Policy Law, 14 (1), 119-134 Jan 2019

• This paper discusses the principal challenges faced when performing economic evaluations of changes to the organisation and delivery of health services and provides recommendations for overcoming them. The five principal challenges identified are: undertaking ex-ante evaluation; evaluating impacts in terms of quality-adjusted life years; assessing costs and opportunity costs; accounting for spillover effects; and generalisability.